Abstract
Regenerative medicine has been progressing based on stem cell, scaffold, and developmental researches. Among them, stem cells or progenitor cells play key roles in regenerative medicine. In plastic surgery, many types of stem or progenitor cells are in clinical use. Keratinocyte progenitor cells have been clinically used as cultured epidermal cells. Bone marrow mesenchymal stem cells and adipose derived stem cells are beginning to be applied in various lesions. Although they have the potential to give benefits to the applied lesion, their effects may come not from the regenerative ability of stem cells but from cytokine effects. In order to progress regenerative medicine in plastic surgery, we have to investigate the mechanism of the benefits of the stem cells after application to the lesion.
| Original language | English |
|---|---|
| Pages (from-to) | 1055-1059 |
| Number of pages | 5 |
| Journal | Japanese Journal of Plastic Surgery |
| Volume | 55 |
| Issue number | 10 |
| Publication status | Published - 2012 Oct 1 |
ASJC Scopus subject areas
- Surgery